What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Jan A.M. Smeitink focuses on Mitochondrion, Genetics, Mutation, Oxidative phosphorylation and Gene.
His Mitochondrion research is multidisciplinary, incorporating perspectives in Molecular biology, Mitochondrial DNA, Mitochondrial disease and Mitochondrial translation.
The study incorporates disciplines such as Biomarker, Respiratory chain and Pathology in addition to Mitochondrial disease.
His Mutation research includes elements of Endocrinology, Complementary DNA, Complementation, Internal medicine and Peptide sequence.
His Oxidative phosphorylation research is included under the broader classification of Biochemistry.
His research integrates issues of RNA interference, Protein subunit and Neurospora crassa in his study of Cell biology.
His most cited work include:
- A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? (1368 citations)
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy (783 citations)
- Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. (767 citations)
What are the main themes of his work throughout his whole career to date?
Jan A.M. Smeitink mainly investigates Mitochondrion, Mitochondrial disease, Genetics, Internal medicine and Oxidative phosphorylation.
His Mitochondrion study introduces a deeper knowledge of Cell biology.
His Mitochondrial disease study also includes fields such as
- Pathology that connect with fields like Cardiomyopathy,
- Respiratory chain that intertwine with fields like Mitochondrial respiratory chain.
His work deals with themes such as Gastroenterology, Endocrinology and Mitochondrial myopathy, which intersect with Internal medicine.
His biological study spans a wide range of topics, including Oxidoreductase and Biogenesis.
Jan A.M. Smeitink combines subjects such as NDUFS4 and Molecular biology with his study of Mutation.
He most often published in these fields:
- Mitochondrion (29.50%)
- Mitochondrial disease (27.70%)
- Genetics (23.87%)
What were the highlights of his more recent work (between 2013-2021)?
- Mitochondrial disease (27.70%)
- Mitochondrion (29.50%)
- Internal medicine (21.17%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Mitochondrial disease, Mitochondrion, Internal medicine, Mitochondrial DNA and Oxidative phosphorylation.
His Mitochondrial disease research entails a greater understanding of Genetics.
His Mitochondrion study combines topics from a wide range of disciplines, such as Cell, Anesthesia, Biophysics, Membrane potential and mitochondrial fusion.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Endocrinology.
His Mitochondrial DNA research integrates issues from Lactic acidosis and Molecular biology.
Oxidative phosphorylation is a subfield of Biochemistry that Jan A.M. Smeitink studies.
Between 2013 and 2021, his most popular works were:
- Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition (125 citations)
- Whole exome sequencing of suspected mitochondrial patients in clinical practice (124 citations)
- A guide to diagnosis and treatment of Leigh syndrome (104 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
The scientist’s investigation covers issues in Mitochondrial disease, Mitochondrion, Oxidative phosphorylation, Internal medicine and Genetics.
His studies in Mitochondrial disease integrate themes in fields like Mutation, Leigh disease, Biomarker and Pathology.
His Mitochondrion study combines topics in areas such as Pyruvate dehydrogenase deficiency, Cell, Bioinformatics, Rational design and mitochondrial fusion.
Oxidative phosphorylation is a subfield of Biochemistry that he explores.
His Internal medicine study incorporates themes from Gastroenterology, Endocrinology and Crossover study.
Genetics and Computational biology are commonly linked in his work.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
